Description
While the abstract identifies β-catenin’s involvement in myofibroblast activation and subsequent fibrosis, the specific molecular mechanisms linking β-catenin signaling to fibroblast-to-myofibroblast transition remain unexplained. This knowledge gap limits development of anti-fibrotic therapies.
Gap type: unexplained_observation Source paper: Multi‑layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/β‑catenin signaling activation (Review). (None, None, PMID:29786110)